
Image Analysis Group (IAG) is a pioneering imaging Clinical Research Organization (iCRO) that combines medical expertise, operational excellence, and advanced AI technology to accelerate drug development. Since 2007, IAG has partnered with global biotech and pharmaceutical companies to manage imaging across Phase I-III clinical trials and real-world evidence studies in various therapeutic areas. Their proprietary DYNAMIKA platform offers award-winning digital data management, ensuring data integrity and streamlined trial execution. IAG's innovative AI-powered endpoints enhance safety and efficacy assessments, supporting efficient trial design and delivery worldwide. With a global operational presence and extensive therapeutic expertise, IAG is positioned as a trusted partner driving faster development of novel therapies.

Image Analysis Group (IAG) is a pioneering imaging Clinical Research Organization (iCRO) that combines medical expertise, operational excellence, and advanced AI technology to accelerate drug development. Since 2007, IAG has partnered with global biotech and pharmaceutical companies to manage imaging across Phase I-III clinical trials and real-world evidence studies in various therapeutic areas. Their proprietary DYNAMIKA platform offers award-winning digital data management, ensuring data integrity and streamlined trial execution. IAG's innovative AI-powered endpoints enhance safety and efficacy assessments, supporting efficient trial design and delivery worldwide. With a global operational presence and extensive therapeutic expertise, IAG is positioned as a trusted partner driving faster development of novel therapies.
Company Description
Image Analysis Group (IAG) is a trusted partner to life sciences companies, specializing in leveraging medical imaging and its AI-enabled platform, DYNAMIKA, to optimize clinical drug development. IAG designs and executes imaging strategies for clinical trials, with special focus on obesity, rheumatology / immunology, oncology and neuro-oncology. By focusing on radiological endpoints, the team ensures the our clients have objective evidence of drug efficacy and safety. With nearly 20 years of experience and contributions to over 700 clinical trials, IAG empowers biotech and pharmaceutical sponsors to make confident, data-driven decisions.
Role Summary
As a key member of IAG’s Scientific and Medical Services team and in collaboration with our global scientific advisory board, you will lead discussions and provide strategic advice on imaging endpoints and trial design for our biotech and pharmaceutical clients. You will support the delivery of imaging biomarker research across therapeutic areas such as oncology, rheumatology, metabolic disorders (including obesity and diabetes), rare diseases, and CNS disorders.
This role involves direct engagement with C-level executives, business development, product, and project management teams, ensuring alignment between client needs and scientific innovation. You will also actively represent IAG at scientific conferences and contribute to publications, helping clients maximize the value extracted from their imaging data to accelerate drug development.
Key Responsibilities:
Requirements
Why work at Image Analysis Group?